RCK’s feature in The Times: Lord Philip Hammond joining as a Senior Advisor

Although the R&D tax relief scheme was not directly mentioned in Labour's manifesto, Labour's overall message suggests the scheme is not set to undergo significant change, which should comfort businesses seeking to invest in R&D. In this article, we discuss the scheme's history and our predictions for its future.

On Wednesday, Jeremy Hunt addressed the UK from Parliament and delivered the Autumn Statement, outlining a number of measures which will impact our business and clients.

With the contagious outbreak announced as a global medical emergency, the pandemic provided a new challenge for pharmaceutical companies to make an impact, looking to streamline drug development, decentralise testing centres and develop new assured point-of-care testing.